These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19916881)

  • 1. Pelvic exenteration for gynecological malignancies: an analysis of 15 cases operated on at a single institution.
    Mäenpää JU; Kangasniemi K; Luukkaala T
    Acta Obstet Gynecol Scand; 2010; 89(2):279-83. PubMed ID: 19916881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pelvic exenteration of advanced gynecological malignacies: a report of 18 cases].
    Zhang Z; Zang R; Chen J
    Zhonghua Fu Chan Ke Za Zhi; 2000 May; 35(5):288-90. PubMed ID: 11775910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pelvic exenteration. Has it a role in 1987? A six year experience.
    Shepherd JH
    Verh K Acad Geneeskd Belg; 1989; 51(1):31-44; discussion 44-6. PubMed ID: 2800684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major complications of urinary diversion after pelvic exenteration for gynecologic malignancies: a 23-year mono-institutional experience in 124 patients.
    Houvenaeghel G; Moutardier V; Karsenty G; Bladou F; Lelong B; Buttarelli M; Delpero JR
    Gynecol Oncol; 2004 Feb; 92(2):680-3. PubMed ID: 14766266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Laparoscopy-assisted vaginal pelvic exenteration].
    Ferron G; Querleu D; Martel P; Chopin N; Soulié M
    Gynecol Obstet Fertil; 2006 Dec; 34(12):1131-6. PubMed ID: 17134933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies.
    Fotopoulou C; Neumann U; Kraetschell R; Schefold JC; Weidemann H; Lichtenegger W; Sehouli J
    J Surg Oncol; 2010 May; 101(6):507-12. PubMed ID: 20401918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors in pelvic exenteration for gynecological malignancies.
    Baiocchi G; Guimaraes GC; Rosa Oliveira RA; Kumagai LY; Faloppa CC; Aguiar S; Begnami MD; Soares FA; Lopes A
    Eur J Surg Oncol; 2012 Oct; 38(10):948-54. PubMed ID: 22818842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indications for primary and secondary exenterations in patients with cervical cancer.
    Marnitz S; Köhler C; Müller M; Behrens K; Hasenbein K; Schneider A
    Gynecol Oncol; 2006 Dec; 103(3):1023-30. PubMed ID: 16890276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of recurrent adenocarcinoma of the endometrium with pelvic exenteration.
    Morris M; Alvarez RD; Kinney WK; Wilson TO
    Gynecol Oncol; 1996 Feb; 60(2):288-91. PubMed ID: 8631553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ileal orthotopic neobladder after pelvic exenteration for cervical cancer.
    Chiva LM; Lapuente F; Núñez C; Ramírez PT
    Gynecol Oncol; 2009 Apr; 113(1):47-51. PubMed ID: 19176235
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pelvic exenteration for primary and recurrent gynaecological malignancies.
    de Wilt JH; van Leeuwen DH; Logmans A; Verhoef C; Kirkels WJ; Vermaas M; Ansink AC
    Eur J Obstet Gynecol Reprod Biol; 2007 Oct; 134(2):243-8. PubMed ID: 16950559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration for recurrent endometrial cancer.
    Barakat RR; Goldman NA; Patel DA; Venkatraman ES; Curtin JP
    Gynecol Oncol; 1999 Oct; 75(1):99-102. PubMed ID: 10502433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration, University of Michigan: 100 patients at 5 years.
    Morley GW; Hopkins MP; Lindenauer SM; Roberts JA
    Obstet Gynecol; 1989 Dec; 74(6):934-43. PubMed ID: 2586960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anterior pelvic exenteration with total vaginectomy for recurrent or persistent genitourinary malignancies: review of surgical technique, complications, and outcome.
    Andikyan V; Khoury-Collado F; Gerst SR; Talukdar S; Bochner BH; Sandhu JS; Abu-Rustum N; Sonoda Y; Barakat RR; Chi DS
    Gynecol Oncol; 2012 Sep; 126(3):346-50. PubMed ID: 22555107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic exenteration for primary and recurrent vulvar cancer.
    Miller B; Morris M; Levenback C; Burke TW; Gershenson DM
    Gynecol Oncol; 1995 Aug; 58(2):202-5. PubMed ID: 7622106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined surgical and radiotherapeutic treatment of pelvic wall recurrences: report of experiences after 3 years].
    Höckel M; Knapstein PG; Hohenfellner R; Rösler HP; Kutzner J
    Geburtshilfe Frauenheilkd; 1993 Mar; 53(3):169-76. PubMed ID: 8467983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic exenteration affords safe and durable treatment for locally advanced rectal carcinoma.
    Gannon CJ; Zager JS; Chang GJ; Feig BW; Wood CG; Skibber JM; Rodriguez-Bigas MA
    Ann Surg Oncol; 2007 Jun; 14(6):1870-7. PubMed ID: 17406945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall.
    Höckel M; Sclenger K; Hamm H; Knapstein PG; Hohenfellner R; Rösler HP
    Cancer; 1996 May; 77(9):1918-33. PubMed ID: 8646694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pelvic exenteration for malignant melanomas of the vagina or urethra with over 3 mm of invasion.
    Geisler JP; Look KY; Moore DA; Sutton GP
    Gynecol Oncol; 1995 Dec; 59(3):338-41. PubMed ID: 8522251
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.